Vimarsana
Biggest News Aggregation in the World

Williamb Schultz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Williamb Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Williamb Schultz Today - Breaking & Trending Today

CBS Airs NSA Propaganda Informercial Masquerading As 'Hard Hitting' 60 Minutes Journalism By Reporter With Massive Conflict Of Interest - Vimarsana News

CBS Airs NSA Propaganda Informercial Masquerading As 'Hard Hitting' 60 Minutes Journalism By Reporter With Massive Conflict Of Interest

Last night I started seeing a bunch of folks on Twitter absolutely trashing 60 Minutes. We had mentioned last week that 60 Minutes would be doing something about the NSA, including the revelation that some NSA officials favored granting Snowden asylum, and that Keith Alexander ridiculously stated that people should be held accountable for their…

Oswego man accused of threatening state troopers - Vimarsana News

Oswego man accused of threatening state troopers

OSWEGO –- An Oswego man is accused of calling the regional headquarters of the New York State Police and threatening to harm a dispatcher and a trooper.

How an Unproven Alzheimer's Drug Got Approved - The New York Times - Vimarsana News

How an Unproven Alzheimer's Drug Got Approved - The New York Times

How an Unproven Alzheimer’s Drug Got Approved Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab. The F.D.A. conducted an internal inquiry this year after allegations were made that the agency was collaborating too closely with Biogen, maker of the Alzheimer’s drug Aduhelm.Credit...Andrew Kelly/Reuters Published July 19, 2021Updated July 20, 2021, 9:29 a.m. ET Two months before the Food and Drug Administration’s deadline to decide whether to approve Biogen’...

F.D.A. Still Lacks a Permanent Commissioner - The New York Times - Vimarsana News

F.D.A. Still Lacks a Permanent Commissioner - The New York Times

With the pandemic easing, the federal agency’s long-term agenda for drug approvals or new issues is languishing without a permanent commissioner.

F.D.A. Still Lacks a Permanent Commissioner - Vimarsana News

F.D.A. Still Lacks a Permanent Commissioner

The contested decision by the Food and Drug Administration earlier this week to approve a drug to treat Alzheimer’s has renewed concerns about the Biden administration’s prolonged delay in choosing a permanent commissioner to lead the agency. It has also once again exposed the sharp divide between supporters and detractors of the F.D.A.’s interim commissioner, Dr. Janet Woodcock, the longtime chief of the agency’s drug division who has seemed to...

Source: msn.com